Binay Shah/LinkedIn
Aug 3, 2025, 11:42
Binay Shah: Binaytara Oncology Survey on Ivermectin Use in Cancer Care
Binay Shah, President of the Binaytara Foundation, shared a post on LinkedIn:
“Oncology Colleagues – We Need Your Input
We’ve been hearing more anecdotal reports of patients asking about ivermectin for cancer treatment. To better understand how widespread this is and how providers are responding, we’re conducting a short survey.
Your insights will help us gauge trends, identify education needs, and guide evidence-based conversations with patients.
Take the survey here.
Takes less than 3 minutes.
Let’s work together to ensure our patients get accurate, science-based cancer care.”
More posts featuring Binay Shah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 16:04
Aug 25, 2025, 15:59
Aug 25, 2025, 15:59
Aug 25, 2025, 15:56